Literature DB >> 8739434

Effect of epilepsy, seizures and epileptiform EEG discharges on cognitive function.

A P Aldenkamp1, J Overweg, T Gutter, A M Beun, L Diepman, O G Mulder.   

Abstract

Patients with an established diagnosis of epilepsy were included in three groups on the basis of the absence (Group 2) or presence (Group 3) of epileptiform EEG discharges or subtle seizures (Group 4) during the cognitive assessment procedure. A separate age-matched non-epileptic control group (Group 1) was formed. Twenty-five patients were included in each of the four groups. Thus, a total of 100 patients were investigated. The patients were assessed with continuous 21-channel EEG and video-monitoring, combined with cognitive testing. The results show consistently lower performance on cognitive tests for Group 4, the group with subtle seizures. The difference with the control group was significant for the intelligence subtests and for the complex information processing test (p < 0.05). No transient cognitive impairment was found. The results are discussed in the light of possible factors that may be responsible for the lower test-scores in the patients of Group 4: both the ictal effects of the seizures themselves, postictal effects and the effects of the epileptiform EEG discharges may have had an impact on cognitive performance. Finally the absence of evidence for transient cognitive impairment in a group with frequent epileptiform EEG discharges is discussed in detail.

Entities:  

Mesh:

Year:  1996        PMID: 8739434     DOI: 10.1111/j.1600-0404.1996.tb00516.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats.

Authors:  Devon L Graham; Nicole R Herring; Tori L Schaefer; Katherine D Holland; Charles V Vorhees; Michael T Williams
Journal:  Open Neuropsychopharmacol J       Date:  2012

2.  Extrahippocampal gray matter atrophy and memory impairment in patients with medial temporal lobe epilepsy.

Authors:  Leonardo Bonilha; Andréa Alessio; Chris Rorden; Gordon Baylis; Benito P Damasceno; Li Li Min; Fernando Cendes
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

3.  Increased EEG current-source density in the high Beta frequency band induced by levetiracetam adjunctive therapy in refractory partial epilepsy.

Authors:  Sung-Pa Park; Oh-Young Kwon
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

4.  Nonconvulsive seizures and dementia: a case report.

Authors:  Campana Chiara; Assenza Giovanni; Pellegrino Giovanni; Benvenga Antonella; Assenza Federica; Ursini Francesca; Vernieri Fabrizio; Tombini Mario
Journal:  Int J Alzheimers Dis       Date:  2011-04-13

5.  Loss of hippocampal neurons after kainate treatment correlates with behavioral deficits.

Authors:  Gisela H Maia; José L Quesado; Joana I Soares; Joana M do Carmo; Pedro A Andrade; José P Andrade; Nikolai V Lukoyanov
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

6.  Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy.

Authors:  Ghaydaa A Shehata; Abd El-aziz M Bateh; Sherifa A Hamed; Tarek A Rageh; Yaser B Elsorogy
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570

7.  Imaging the interaction: epileptic discharges, working memory, and behavior.

Authors:  Umair J Chaudhary; Maria Centeno; David W Carmichael; Christian Vollmar; Roman Rodionov; Silvia Bonelli; Jason Stretton; Ronit Pressler; Sofia H Eriksson; Sanjay Sisodiya; Karl Friston; John S Duncan; Louis Lemieux; Matthias Koepp
Journal:  Hum Brain Mapp       Date:  2012-06-19       Impact factor: 5.038

8.  Comparison of cognitive effects of lamotrigine and oxcarbazepine in epilepsy patients.

Authors:  Jong-Geun Seo; Da-In Lee; Yang-Ha Hwang; Ho-Won Lee; Doo-Kyo Jung; Chung-Kyu Suh; Soon-Hak Kwon; Sung-Pa Park
Journal:  J Clin Neurol       Date:  2007-03-20       Impact factor: 3.077

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.